PM360 | August 21, 2019 - Pharma marketers, publishers and agencies agree: content is key to standing out in an increasingly competitive marketplace. Recognizing the significance of content, brands have historically invested in resources on their owned and operated sites, social programs and publisher sponsorships. Yet content marketers are at a loss when it comes to calculating the holistic impact of their investment. Publishers rely on proprietary methodologies and benchmarks, while the different teams managing paid, owned and social channels often fail to share learnings, overall resulting in inconsistent measurement and insights.
Successful content marketing requires understanding how content influences behavior throughout the patient journey. Only through holistic measurement and strategic distribution can pharma marketers ensure that they are investing in content that will drive bottom-line impact for their brands.
Brands that embrace predictive, engagement-driven audience building will set themselves up for stronger performance in the years ahead
Read More
Delivered to Better Audiences: How to Unlock Incrementality in 2025
Brands need to reach audiences in environments that enhance trust, attention, and brand favorability
Read More
Served in Better Places: Why Direct Publisher Access Matters More Than Ever
Better insights both inform your strategy and actively improve it, every step of the way
Read More
Validated by Better Insights: Why Deeper Intelligence Is the New Competitive Advantage
